Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458483 · ClinicalTrials.gov registry record · Phase 1
Acute Carotid Sinus Endovascular Stimulation II Study
A Phase 1 study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT01458483 is a Phase 1 study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 9 participants.
The verdict
NCT01458483, a Phase 1 study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The Acute Carotid Sinus Endovascular Stimulation II (ACES II) Study is a multicenter, prospective, non-randomized study that is being conducted to evaluate the feasibility of endovascular stimulation of carotid sinus nerves via an electrophysiology (EP) catheter advanced into the internal jugular vein (IJV). The current study investigates the hypothesis that intraoperative electrical stimulation of the carotid sinus from the IJV will result in an acute and dose-dependent reduction in blood pressure and heart rate.
Interventions
- DEVICE Baroreceptor Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01458483
The ClinicalTrials.gov registry entry for NCT01458483 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baroreceptor Stimulation is the first listed.
NCT01458483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01458483 about?
NCT01458483 is a clinical study titled "Acute Carotid Sinus Endovascular Stimulation II Study". The Acute Carotid Sinus Endovascular Stimulation II (ACES II) Study is a multicenter, prospective, non-randomized study that is being conducted to evaluate the feasibility of endovascular stimulation of carotid sinus nerves via an electrophysiology (EP) catheter advanced into the internal jugular ve...
What is the current status of trial NCT01458483?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2011-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01458483?
The interventions under investigation include: Baroreceptor Stimulation (DEVICE).
Who is sponsoring clinical trial NCT01458483?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.